Plain-English translation of NCT05019495 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a proactive approach to smoking cessation works better than the standard approach for people living with HIV. In the proactive program, a clinical pharmacist will actively contact you three times to help you access smoking cessation medications and provide counseling and motivational support. The goal is to help more people quit smoking and reduce serious health problems caused by smoking.
People with HIV who smoke face extra health risks, but many don't receive the smoking cessation support they need. This trial exists to find out whether actively reaching out to patients—rather than waiting for them to ask for help—can increase the number of people who successfully quit smoking and improve their overall health.
You likely qualify if…
You likely don't qualify if…
If you're assigned to the standard group, you'll follow your usual clinic pathways and can access smoking cessation medication from the clinic pharmacist. If you're assigned to the proactive group, the clinical pharmacist will contact you three times to help you get medication and will provide brief counseling and motivational support. You'll be followed for at least 12 weeks, with assessments of your smoking status and other health markers.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States
Sponsor
Medical University of South Carolina
Collaborators
National Cancer Institute (NCI)
Enrollment target
~231 participants
Started
December 2021
Primary completion
February 2027
Age range
21 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chloe Morone
Medical University of South Carolina
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.